Check how common medications affect tattoo and piercing procedures. Covers blood thinners, retinoids, immunosuppressants, antibiotics, and more — with specific risks and recommended wait periods.
"A client on warfarin who doesn't mention it is a liability risk for the studio and a genuine clinical risk for themselves. This checker is my attempt to systematize the medication conversation that every studio should be having but rarely does in a structured way. It doesn't replace a prescriber's advice — but it puts the right questions on the table."
Founder & Piercing Expert
Clinical History Verified
Paste this snippet anywhere on your site — free to use, no account required.
<iframe
src="https://poliinternational.com/tools/medication-interaction-checker/index.html"
width="100%"
height="800"
style="border:none;border-radius:12px;"
loading="lazy"
title="Medication & Body Art Interaction Checker">
</iframe>Anticoagulants (warfarin, apixaban, rivaroxaban) and antiplatelet drugs (aspirin, clopidogrel) impair the clotting cascade that controls bleeding during and after a procedure. In tattooing, excessive bleeding dilutes the ink carrier as it is being implanted, leading to poor pigment retention and requiring additional passes that increase skin trauma. In piercing, prolonged bleeding can pool around the jewelry and increase infection risk. Some anticoagulants also delay the inflammatory phase of healing, extending the timeline for the fistula to organize.
No. Isotretinoin is a retinoid that dramatically alters skin biology — it reduces sebaceous gland activity and significantly thins the stratum corneum. During isotretinoin treatment and for a minimum of 6 months after completing a course, skin is structurally compromised. Tattoo ink will not heal predictably, scarring risk is elevated, and infection risk is higher due to impaired barrier function. Most professional tattoo artists refuse to work on clients currently taking or recently completing isotretinoin. The 6-month minimum wait allows for full skin recovery before any body art procedure.
Immunosuppressants — including biologics (adalimumab, etanercept), methotrexate, and ciclosporin — suppress the body's inflammatory response that is essential for wound healing. The inflammatory phase of piercing healing (days 1–7) is the mechanism by which white blood cells clear bacteria and initiate the repair cascade. With a suppressed immune response, this phase is attenuated, infection thresholds are lower, and the transition to the proliferative phase takes longer. Clients on immunosuppressants should discuss any body art procedure with their prescribing physician before proceeding.
Get notified when we release new professional tools for tattoo and piercing artists.